REGINA DUBOIS-RODABAUGH: Open Payments
NPI 1730481953 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 22 payments from 7 companies in 2025. Trend: 2023 $281 · 2024 $679 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $266 |
| Axsome Therapeutics, Inc. | 3 | $144 |
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, Auvelity, COBENFY, INGREZZA, CAPLYTA, MOUNJARO, QULIPTA, Jornay PM.
Industry payments across FL — which companies pay providers there.
